Revenue, last quarter
$22K
−15.4% vs same quarter last year
Net income
−$3.1M
+4.3% vs same quarter last year
EPS, diluted
−$0.21
+86.6% vs same quarter last year
Operating cash flow
−$2.9M
+42.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $88K | −$14M |
| FY24 | $170K | −$17.3M |
| FY23 | $202K | −$29M |
| FY22 | $141K | −$19.4M |
| FY21 | $135K | −$19.1M |
| FY20 | $163K | −$14.4M |
| FY19 | $140K | −$9.4M |
| FY18 | $367K | −$9.8M |
| FY17 | $437K | −$8.3M |
| FY16 | $92K | −$7.5M |
| FY15 | $133K | −$15.2M |
| FY14 | $197K | −$17.5M |
| FY13 | $150K | −$16.2M |
| FY12 | $213K | −$17.4M |
| FY11 | $161K | −$9M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −13254.5% | −15861.4% |
| FY24 | −11630.6% | −10188.2% |
| FY23 | −15800% | −14337.6% |
| FY22 | −14129.8% | −13790.8% |
| FY21 | −13954.1% | −14168.1% |
| FY20 | −9295.7% | −8834.4% |
| FY19 | −8887.9% | −6717.1% |
| FY18 | −3132.4% | −2677.7% |
| FY17 | −2612.4% | −1889.9% |
| FY16 | −15004.3% | −8154.3% |
| FY15 | −12518.8% | −11451.1% |
| FY14 | −9694.9% | −8857.9% |
| FY13 | −11444.7% | −10816.7% |
| FY12 | −9549.3% | −8147.4% |
| FY11 | −8878.9% | −5599.4% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | −$14.9M |
| FY23 | - |
| FY22 | −$16.2M |
| FY21 | −$14M |
| FY20 | −$10.4M |
| FY19 | −$9.1M |
| FY18 | −$10.7M |
| FY17 | −$8M |
| FY16 | −$7.5M |
| FY15 | −$16.3M |
| FY14 | −$14.5M |
| FY13 | −$17.7M |
| FY12 | −$18.9M |
| FY11 | −$11.9M |
- AIM ImmunoTech
- Healthcare median
Show the numbers
| Year | AIM ImmunoTech | Healthcare median |
|---|---|---|
| FY25 | −15861.4% | −30.6% |
| FY24 | −10188.2% | −47% |
| FY23 | −14337.6% | −58% |
| FY22 | −13790.8% | −80.4% |
| FY21 | −14168.1% | −71.9% |
| FY20 | −8834.4% | −62.2% |
| FY19 | −6717.1% | −46.3% |
| FY18 | −2677.7% | −49.6% |
| FY17 | −1889.9% | −45.9% |
| FY16 | −8154.3% | −36% |
| FY15 | −11451.1% | −38.4% |
| FY14 | −8857.9% | −35.5% |
| FY13 | −10816.7% | −37.1% |
| FY12 | −8147.4% | −29.1% |
| FY11 | −5599.4% | −27.9% |